383 related articles for article (PubMed ID: 28985438)
1. Structural differences between glycosylated, disulfide-linked heterodimeric Knob-into-Hole Fc fragment and its homodimeric Knob-Knob and Hole-Hole side products.
Kuglstatter A; Stihle M; Neumann C; Müller C; Schaefer W; Klein C; Benz J;
Protein Eng Des Sel; 2017 Sep; 30(9):649-656. PubMed ID: 28985438
[TBL] [Abstract][Full Text] [Related]
2. Antiparallel conformation of knob and hole aglycosylated half-antibody homodimers is mediated by a CH2-CH3 hydrophobic interaction.
Elliott JM; Ultsch M; Lee J; Tong R; Takeda K; Spiess C; Eigenbrot C; Scheer JM
J Mol Biol; 2014 May; 426(9):1947-57. PubMed ID: 24576605
[TBL] [Abstract][Full Text] [Related]
3. Production of bispecific antibodies in "knobs-into-holes" using a cell-free expression system.
Xu Y; Lee J; Tran C; Heibeck TH; Wang WD; Yang J; Stafford RL; Steiner AR; Sato AK; Hallam TJ; Yin G
MAbs; 2015; 7(1):231-42. PubMed ID: 25427258
[TBL] [Abstract][Full Text] [Related]
4. Engineering of Immunoglobulin Fc Heterodimers Using Yeast Surface-Displayed Combinatorial Fc Library Screening.
Choi HJ; Kim YJ; Choi DK; Kim YS
PLoS One; 2015; 10(12):e0145349. PubMed ID: 26675656
[TBL] [Abstract][Full Text] [Related]
5. Structure of the Fc fragment of the NIST reference antibody RM8671.
Gallagher DT; Galvin CV; Karageorgos I
Acta Crystallogr F Struct Biol Commun; 2018 Sep; 74(Pt 9):524-529. PubMed ID: 30198883
[TBL] [Abstract][Full Text] [Related]
6. Stabilisation of the Fc fragment of human IgG1 by engineered intradomain disulfide bonds.
Wozniak-Knopp G; Stadlmann J; Rüker F
PLoS One; 2012; 7(1):e30083. PubMed ID: 22272277
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of immunoglobulin Fc heterodimers reveal the molecular basis for heterodimer formation.
Choi HJ; Seok SH; Kim YJ; Seo MD; Kim YS
Mol Immunol; 2015 Jun; 65(2):377-83. PubMed ID: 25743157
[TBL] [Abstract][Full Text] [Related]
8. SEEDbodies: fusion proteins based on strand-exchange engineered domain (SEED) CH3 heterodimers in an Fc analogue platform for asymmetric binders or immunofusions and bispecific antibodies.
Davis JH; Aperlo C; Li Y; Kurosawa E; Lan Y; Lo KM; Huston JS
Protein Eng Des Sel; 2010 Apr; 23(4):195-202. PubMed ID: 20299542
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin domain interface exchange as a platform technology for the generation of Fc heterodimers and bispecific antibodies.
Skegro D; Stutz C; Ollier R; Svensson E; Wassmann P; Bourquin F; Monney T; Gn S; Blein S
J Biol Chem; 2017 Jun; 292(23):9745-9759. PubMed ID: 28450393
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive elucidation of the structural and functional roles of engineered disulfide bonds in antibody Fc fragment.
Zeng F; Yang C; Gao X; Li X; Zhang Z; Gong R
J Biol Chem; 2018 Dec; 293(49):19127-19135. PubMed ID: 30327432
[TBL] [Abstract][Full Text] [Related]
11. Full-length recombinant antibodies from
Rashid MH
MAbs; 2022; 14(1):2111748. PubMed ID: 36018829
[TBL] [Abstract][Full Text] [Related]
12. TriFabs--Trivalent IgG-Shaped Bispecific Antibody Derivatives: Design, Generation, Characterization and Application for Targeted Payload Delivery.
Mayer K; Baumann AL; Grote M; Seeber S; Kettenberger H; Breuer S; Killian T; Schäfer W; Brinkmann U
Int J Mol Sci; 2015 Nov; 16(11):27497-507. PubMed ID: 26593903
[TBL] [Abstract][Full Text] [Related]
13. IgG2 Fc structure and the dynamic features of the IgG CH2-CH3 interface.
Teplyakov A; Zhao Y; Malia TJ; Obmolova G; Gilliland GL
Mol Immunol; 2013 Nov; 56(1-2):131-9. PubMed ID: 23628091
[TBL] [Abstract][Full Text] [Related]
14. Computationally Designed Bispecific Antibodies using Negative State Repertoires.
Leaver-Fay A; Froning KJ; Atwell S; Aldaz H; Pustilnik A; Lu F; Huang F; Yuan R; Hassanali S; Chamberlain AK; Fitchett JR; Demarest SJ; Kuhlman B
Structure; 2016 Apr; 24(4):641-651. PubMed ID: 26996964
[TBL] [Abstract][Full Text] [Related]
15. A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G
De Nardis C; Hendriks LJA; Poirier E; Arvinte T; Gros P; Bakker ABH; de Kruif J
J Biol Chem; 2017 Sep; 292(35):14706-14717. PubMed ID: 28655766
[TBL] [Abstract][Full Text] [Related]
16. Rapid Purification of Human Bispecific Antibodies via Selective Modulation of Protein A Binding.
Zwolak A; Leettola CN; Tam SH; Goulet DR; Derebe MG; Pardinas JR; Zheng S; Decker R; Emmell E; Chiu ML
Sci Rep; 2017 Nov; 7(1):15521. PubMed ID: 29138497
[TBL] [Abstract][Full Text] [Related]
17. A C-terminal interdomain disulfide bond significantly stabilizes the Fc fragment of IgG.
Wozniak-Knopp G; Rüker F
Arch Biochem Biophys; 2012 Oct; 526(2):181-7. PubMed ID: 22483683
[TBL] [Abstract][Full Text] [Related]
18. Bispecific antibody process development: Assembly and purification of knob and hole bispecific antibodies.
Giese G; Williams A; Rodriguez M; Persson J
Biotechnol Prog; 2018 Mar; 34(2):397-404. PubMed ID: 29193902
[TBL] [Abstract][Full Text] [Related]
19. Structural consequences of aglycosylated IgG Fc variants evolved for FcγRI binding.
Ju MS; Na JH; Yu YG; Kim JY; Jeong C; Jung ST
Mol Immunol; 2015 Oct; 67(2 Pt B):350-6. PubMed ID: 26153451
[TBL] [Abstract][Full Text] [Related]
20. Engineering the fragment crystallizable (Fc) region of human IgG1 multimers and monomers to fine-tune interactions with sialic acid-dependent receptors.
Blundell PA; Le NPL; Allen J; Watanabe Y; Pleass RJ
J Biol Chem; 2017 Aug; 292(31):12994-13007. PubMed ID: 28620050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
